Kochav Defense Acquisition Corp. completes $253M IPO, targeting defense/aerospace deals

Kochav Defense Acquisition Corp.

IPO of 25.3M units at $10.00 each, raising $253M gross proceeds (including full over-allotment); units trade on Nasdaq under KCHVU.
Private placement of 524,050 units at $10.00 each to sponsor Kochav Sponsor LLC for $5.24M.
$253M placed in trust account; company has 18–24 months to complete an initial business combination.
Management led by CEO Menny Shalom and CFO Asaf Yarkoni; independent directors appointed.
Company intends to focus on defense and aerospace industries for its business combination.

item 1.01item 3.02item 5.02item 5.03item 8.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Yair Ramati

Director

KCHV · Kochav Defense Acquisition Corp.

Effective: 2025-05-27
Filed: May 29, 2025 23:59 UTC

On May 27, 2025, in connection with the IPO, Doron Dovrat, Yair Ramati and Gill Zaphrir (collectively with Menachem Shalom, the “Directors”) were appointed to the board of directors of the Company

Appointed

Doron Dovrat

Director

KCHV · Kochav Defense Acquisition Corp.

Effective: 2025-05-27
Filed: May 29, 2025 23:59 UTC

On May 27, 2025, in connection with the IPO, Doron Dovrat, Yair Ramati and Gill Zaphrir (collectively with Menachem Shalom, the “Directors”) were appointed to the board of directors of the Company

Appointed

Gill Zaphrir

Director

KCHV · Kochav Defense Acquisition Corp.

Effective: 2025-05-27
Filed: May 29, 2025 23:59 UTC

On May 27, 2025, in connection with the IPO, Doron Dovrat, Yair Ramati and Gill Zaphrir (collectively with Menachem Shalom, the “Directors”) were appointed to the board of directors of the Company

Source: SEC EDGAR

accession 0001213900-25-048986

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.